Parkman Healthcare Partners’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,727,925
| Closed | -$3.18M | – | 103 |
|
|
2024
Q4 | $3.18M | Buy |
1,727,925
+11,793
| +0.7% | +$21.7K | 0.42% | 59 |
|
|
2024
Q3 | $5.94M | Sell |
1,716,132
-76,608
| -4% | -$265K | 0.76% | 46 |
|
|
2024
Q2 | $5.25M | Buy |
1,792,740
+2,689
| +0.2% | +$7.88K | 0.7% | 51 |
|
|
2024
Q1 | $10.1M | Buy |
1,790,051
+587,620
| +49% | +$3.32M | 1.24% | 32 |
|
|
2023
Q4 | $5.16M | Buy |
1,202,431
+20,263
| +2% | +$86.9K | 0.73% | 43 |
|
|
2023
Q3 | $4.1M | Buy |
1,182,168
+38,307
| +3% | +$133K | 0.75% | 38 |
|
|
2023
Q2 | $5.32M | Buy |
1,143,861
+43,823
| +4% | +$204K | 0.92% | 34 |
|
|
2023
Q1 | $5.08M | Buy |
1,100,038
+234,063
| +27% | +$1.08M | 1.11% | 36 |
|
|
2022
Q4 | $7M | Buy |
865,975
+178,640
| +26% | +$1.44M | 1.86% | 16 |
|
|
2022
Q3 | $3.82M | Buy |
687,335
+502,817
| +273% | +$2.79M | 1.08% | 29 |
|
|
2022
Q2 | $961K | Sell |
184,518
-15,328
| -8% | -$79.8K | 0.35% | 59 |
|
|
2022
Q1 | $1.64M | Sell |
199,846
-21,373
| -10% | -$176K | 0.48% | 55 |
|
|
2021
Q4 | $3.29M | Buy |
221,219
+57,830
| +35% | +$861K | 0.73% | 38 |
|
|
2021
Q3 | $3.09M | Hold |
163,389
| – | – | 0.78% | 39 |
|
|
2021
Q2 | $3.04M | Sell |
163,389
-39,307
| -19% | -$731K | 0.66% | 48 |
|
|
2021
Q1 | $4.61M | Sell |
202,696
-63,949
| -24% | -$1.46M | 1.07% | 31 |
|
|
2020
Q4 | $5.79M | Buy |
266,645
+56,645
| +27% | +$1.23M | 1.48% | 26 |
|
|
2020
Q3 | $2.11M | Buy |
+210,000
| New | +$2.11M | 0.56% | 57 |
|